Phibro Animal Health | PAHC - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Align Technology USD 410.55M 52.12M 2026-09
ANI Pharmaceuticals USD 94.86M 3.2M 2026-09
Aurora Cannabis CAD 40.89M 515K 2026-06
Bristol-Myers Squibb USD 1.7B 127M 2026-09
Canopy Growth CAD 33.99M 2.83M 2026-06
Corcept Therapeutics USD 142.04M 14.86M 2026-09
Eli Lilly USD 3.12B 305M 2026-09
Henry Schein USD 819M 12M 2026-09
Idexx Laboratories USD 293.13M 5.04M 2026-09
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Merck USD 2.86B 25M 2026-09
Nektar Therapeutics USD 11.87M 1.7M 2026-03
Pacira USD 950.8M 858.99M 2026-09
Phibro Animal Health USD 78.32M 10.24M 2025-12
Prestige Brands USD 2.08B 2.04B 2026-09
Supernus Pharmaceuticals USD 133.64M 15.41M 2026-06
Zoetis USD 582M 10M 2026-09